US Healthcare: Why We Spend Twice as Much for Worse Outcomes

Let me be real with you — I’ve worked in pharma for more than 13 years, and I’ve seen parts of the healthcare system from the inside.

But you don’t need to work in healthcare to notice that something is wrong.

A routine doctor visit can come with a bill you weren’t expecting. A prescription can cost dramatically more than you thought it would. And sometimes, getting a treatment approved can involve paperwork that seems almost as complicated as the treatment itself.

Then there’s the bigger question:

If the United States spends so much more on healthcare than other wealthy countries, why doesn’t that spending automatically translate into better health outcomes?

That question kept bothering me.

And the answer isn’t simply “bad doctors” or “expensive medicine.”

The U.S. healthcare system is expensive because high prices, administrative complexity, prescription-drug costs, expensive hospital care, insurance fragmentation, and the way healthcare is paid for all stack on top of each other.

I’ve seen enough of the pharmaceutical side to know that the price of a medicine is only one piece of a much larger picture.

So let’s follow the money — and then look at what the latest 2026 healthcare changes could actually mean for patients.

Quick Summary

• The U.S. spends far more on healthcare than the OECD average, both as a share of the economy and per person.
• The biggest cost drivers aren’t just medicines. Healthcare service prices, hospital care, insurance complexity, and administrative overhead all add to the bill.
• Prescription drugs, particularly many brand-name medicines, create another major layer of spending.
• When insurance or primary care is difficult to afford, people may delay treatment until a health problem becomes more serious and expensive.
• 2026 reforms are targeting areas such as Medicare drug prices, prior authorization, and value-based payment models.
• The bigger issue isn’t simply why America spends more. It’s whether patients get enough health, access, and value from all that spending.

The Numbers That Make You Look Twice

The U.S. isn’t just spending a little more on healthcare than other wealthy countries.

The gap is enormous.

Country	Health Spending (% of GDP)
United States	17.2%
Germany	12.3%
OECD average	9.3%

In 2024, the United States spent 17.2% of its GDP on healthcare, compared with 9.3% across the OECD. The U.S. also spent about $14,885 per person, compared with an OECD average of $5,967, using purchasing-power-adjusted figures.

That’s not a small difference. The U.S. is spending dramatically more than the average wealthy country.

But there’s an important distinction here.

These numbers show how much America spends. They don’t, by themselves, prove that higher spending causes worse health outcomes.

Life expectancy and other population-health measures are influenced by much more than medical care. Public health, lifestyle, socioeconomic conditions, prevention, and access to care all play a role.

What the spending figures do make clear is simpler:

America pays an extraordinary amount for healthcare.

So now we need to follow the money.

Where Is All That Extra Money Going?

That’s where the story gets more complicated — and where the biggest cost drivers start to become visible.

 

1. Administrative Complexity Adds a Huge Layer of Cost

Let me tell you what I’ve seen firsthand.

A patient may see one doctor for one problem, but that visit can trigger a surprising amount of work behind the scenes: insurance verification, coding, claims processing, billing, prior authorization, documentation, appeals, quality reporting, and payment negotiations.

Each step takes people, software, time, and money.

The Commonwealth Fund estimates that administrative costs associated with insurers and healthcare providers account for roughly 30% of excess U.S. health spending compared with peer nations in its analysis.

That doesn’t mean every person working in administration is unnecessary. The problem is the amount of machinery required to move a relatively simple healthcare transaction through the system.

A patient receives one healthcare service. Behind that service, dozens of administrative tasks may take place.

And those costs don’t simply disappear. They eventually show up somewhere in the healthcare bill — through premiums, employer costs, government spending, or what patients pay themselves.

Why This Matters in 2026

Administrative burden is still a major healthcare policy issue.

Prior-authorization reforms and electronic processing requirements are being introduced to reduce some of the back-and-forth between doctors, insurers, and patients.

That matters because paperwork isn’t free.

When a clinician or office staff member spends hours chasing an approval, that is time and money being spent on administration rather than patient care.

The goal isn’t to eliminate every administrative check. It’s to stop making patients and clinicians fight through unnecessary ones.

2. Drug Prices Are Out of Control

This one hits close to home.

I’ve worked in pharma for more than 13 years, so I know that the price of a medicine isn’t simply the cost of making a tablet, capsule, or injection.

Between manufacturers and patients, there can be wholesalers, pharmacies, insurers, pharmacy benefit managers, rebates, patents, and different payment arrangements.

But patients don’t see all that complexity. They see the price at the pharmacy counter and ask a simple question:

Why does the medicine I need cost so much?

RAND’s international comparison found that U.S. prescription drug prices were about 2.8 times higher than prices in 33 comparison countries overall, based on 2022 manufacturer prices. For brand-name originator drugs, the difference was even larger — about 4.2 times higher.

That doesn’t mean every medicine costs more in the United States. RAND found that unbranded generic drugs were actually cheaper in the U.S. than in most of the countries included in its comparison.

The biggest gap was among brand-name medicines.

Why Are U.S. Drug Prices So Different?

The answer comes down partly to how the U.S. drug market is structured.

Many wealthy countries negotiate or regulate medicine prices through national or centralized systems. The U.S. has historically relied more on negotiations among manufacturers, insurers, pharmacy benefit managers, government programs, and other parts of the market.

Patents can also keep some brand-name medicines expensive for years.

And this isn’t limited to one type of treatment. Newer GLP-1 medications, specialty drugs, and other high-cost therapies can put significant pressure on patients, insurers, and healthcare programs.

That’s why simply saying “drugs cost more in America” doesn’t tell the whole story.

The bigger issue is why so many high-cost and brand-name medicines are priced higher in the United States.

What Is Changing in 2026?

Drug pricing is no longer just a policy debate.

Medicare’s drug-price negotiation program is now producing negotiated prices for selected medicines, with the first negotiated prices taking effect in 2026. Additional drugs are being selected for future negotiation cycles.

That doesn’t mean every patient will suddenly see a lower pharmacy bill. What someone pays can still depend on the medicine, insurance coverage, Medicare plan, and other parts of the payment system.

So yes, drug prices are a major part of America’s healthcare cost problem.

But they’re only one piece of a much larger bill.

3. The ER Is a Safety Net — But It’s an Expensive One

Emergency departments are built for emergencies. They need to be ready around the clock for heart attacks, strokes, serious injuries, severe infections, and other problems that cannot safely wait.

But when someone doesn’t have reliable access to affordable primary care, the ER can become the place they turn when everything else falls through.

That’s where the cost problem gets bigger.

Emergency departments need staff, equipment, imaging, laboratory services, monitoring, and specialist support even when patient demand changes throughout the day. A routine primary-care visit doesn’t require the same level of infrastructure.

So the problem isn’t that every ER visit is unnecessary.

It’s what happens when people end up needing emergency care because they couldn’t get the right care earlier.

Better access to primary care can help catch and manage health problems before they become emergencies. For patients with chronic conditions, consistent outpatient care can also reduce avoidable hospital and emergency-department use.

Sometimes, the most cost-effective healthcare isn’t another hospital service.

It’s getting the patient the right care early enough.

---

4. Being Uninsured Can Turn a Health Problem Into a Financial Problem

Imagine you have a health problem, but you’re worried about the bill.

You postpone the appointment. Then you postpone it again.

Maybe the problem gets worse. Eventually, you may need urgent or emergency care — often at a much higher cost than the earlier treatment might have been.

This isn’t just a financial issue. Delaying care can also make some health conditions harder to manage.

KFF found that in 2024, 38.6% of uninsured adults reported delaying, skipping, or not getting needed healthcare or medicine because of cost. Among uninsured adults under 65, healthcare affordability remains a major barrier.

That creates a difficult cycle: people delay care because they can’t afford it, then face more complicated health problems later.

Chronic conditions make this especially important. Regular monitoring and treatment can help prevent complications that become more expensive to manage.

For example, consistent care is a major part of effective diabetes management.

The cost problem isn’t simply about whether someone has insurance.

It’s also about whether that coverage makes the care they need actually affordable.

5. Fee-for-Service: When the System Pays for Activity

A visit is a service. A procedure is a service. A test is a service.

In a traditional fee-for-service model, healthcare providers are generally paid for the services they deliver. That can create an incentive to do more rather than focus only on whether the patient ultimately gets better.

That doesn’t mean doctors are ordering unnecessary tests or treatments simply to make money. Healthcare decisions are far more complicated than that.

The bigger issue is how the payment structure shapes the system.

If more services generate more payments, the system can naturally lean toward volume instead of value.

That’s one reason healthcare policy has increasingly focused on value-based care — models that put more emphasis on quality, outcomes, prevention, and managing costs.

The goal isn’t simply to pay for fewer services.

It’s to make sure the services being paid for actually improve patient care.

What Can Be Done About Expensive US Healthcare?

There isn’t a single fix for the cost of healthcare in the United States.

Lowering drug prices can help, but it won’t solve hospital costs or administrative waste. Simplifying insurance can reduce paperwork, but patients still need affordable access to doctors and preventive care.

A more effective approach would have to tackle several problems at the same time:

• Reduce unnecessary administrative complexity
• Make prescription drugs more affordable
• Improve access to primary and preventive care
• Encourage healthcare providers to focus on outcomes, not just volume
• Make pricing easier for patients to understand before they receive care

The challenge is finding reforms that reduce waste without reducing access or quality of care.

And that’s where 2026 becomes particularly interesting. Several changes are already moving from policy proposals into actual implementation.

What Is Actually Changing in 2026?

Healthcare policy isn’t changing overnight, but several important reforms are already moving from promises to implementation.

Drug-Price Negotiation Is Becoming Real

Medicare’s drug-price negotiation program is now producing negotiated prices for selected medicines. The first negotiated prices took effect in January 2026, with additional drugs being selected for future negotiation cycles.

This could put downward pressure on spending for some Medicare drugs, but it won’t suddenly make every prescription cheaper. The impact depends on the medicine, the patient’s coverage, and how the negotiated price affects the wider payment system.

Prior Authorization Is Being Challenged

Prior authorization has become another major focus of healthcare reform.

The basic idea is reasonable: insurers may want evidence that an expensive treatment or service is medically appropriate before paying for it.

The problem is what happens when the process becomes slow or unnecessarily complicated.

In 2026, federal reforms are pushing insurers toward faster electronic processes and clearer response requirements for certain services. The aim is to reduce delays without removing legitimate safeguards.

Payment Models Are Also Changing

Healthcare is gradually moving beyond the traditional fee-for-service model.

Value-based payment programs are designed to put more emphasis on quality, outcomes, prevention, and better management of costs rather than simply paying for more services.

These changes won’t fix America’s healthcare costs by themselves.

But they point in the right direction: paying for better care, not simply more care.

---

What Would I Change First?

If I could change one thing about U.S. healthcare, I’d start with making the system easier for patients to navigate.

A patient shouldn’t need to understand insurance terminology, billing codes, prior authorization rules, pharmacy networks, and multiple layers of paperwork just to get basic care.

I’d also put more emphasis on primary and preventive care. Helping people manage health problems earlier can reduce the need for more expensive treatment later.

And on the pharmaceutical side, I’d push for greater transparency around how medicine prices are set and what patients actually pay.

None of these changes would make healthcare cheap overnight.

But they could make the system simpler, more transparent, and more focused on the patient rather than the paperwork surrounding the patient.

Frequently Asked Questions About US Healthcare

Why is US healthcare so expensive? +

The U.S. pays higher prices for many healthcare services, prescription drugs, and hospital care. Administrative complexity, insurance fragmentation, and payment structures also add to overall spending.

Does the US spend more on healthcare than other countries? +

Yes. The U.S. spent 17.2% of GDP on healthcare in 2024, compared with an OECD average of 9.3%.

Why are prescription drugs so expensive in the US? +

Brand-name medicines are a major factor. RAND found that U.S. prescription drug prices were about 2.8 times higher overall than prices in 33 comparison countries, with brand-name originator drugs showing an even larger gap.

Is US healthcare getting cheaper in 2026? +

Not across the board. Some reforms, including Medicare drug-price negotiation, are designed to reduce spending in specific areas, but overall healthcare costs remain high.

Why do Americans use the ER for non-emergency care? +

One reason is limited access to affordable primary care. When people can’t get timely outpatient care, the emergency department may become the easiest place to seek help.

Does fee-for-service make healthcare more expensive? +

It can. Because providers are generally paid for individual services, the model can encourage greater use of healthcare services rather than focusing entirely on outcomes.

Will 2026 healthcare policy changes lower my medical bills? +

They may lower costs for some patients, particularly through Medicare drug-price negotiations, but the effect will vary by insurance coverage, medication, and type of care.

What is the biggest problem with the US healthcare system? +

There isn’t one single problem. High prices, administrative complexity, expensive medicines, uneven access to care, and fragmented payment systems all contribute to the overall cost.

The Bottom Line

So, why is US healthcare so expensive?

There isn’t one culprit.

America pays more for many healthcare services and medicines, carries a huge administrative burden, and still has gaps in affordable access to primary care. The way insurance and healthcare providers are paid adds another layer to the problem.

I’ve worked around the pharmaceutical side of healthcare for more than 13 years, and one thing I’ve learned is that complicated systems can become expensive even when the individual people inside them are simply doing their jobs.

The bigger problem is how all these parts fit together — and whether the system delivers enough value for what Americans spend.

That’s what makes 2026 worth watching.

Medicare drug-price negotiations and reforms around prior authorization and value-based care are trying to reduce unnecessary costs and improve how care is delivered. But for patients, the real test is simple: can they actually afford the care they need?

Good healthcare isn’t just about better treatments. It’s about making sure people can afford to receive them. The goal isn’t healthcare that is merely cheaper — it’s better healthcare at a cost people can live with.

References

1. OECD. Health at a Glance 2025: United States.
2. Commonwealth Fund. High U.S. Health Care Spending: Where Is It All Going?
3. RAND. International Prescription Drug Price Comparisons: Estimates Using 2022 Data.
4. KFF. Key Facts About the Uninsured Population.
5. Centers for Medicare & Medicaid Services. Selected Drugs and Negotiated Prices — Medicare Drug Price Negotiation Program.
6. Centers for Medicare & Medicaid Services. Medicare Drug Price Negotiation Program: Regulations, Guidance, and Policy Documents.